Daratumumab for Patients With Light Chain Amyloidosis

Conditions: Light Chain (AL) Amyloidosis Interventions: Drug: Dratumumab / Hyaluronidase Injection [Darzalex Faspro]; Drug: Pomalidomide 4 MG; Procedure: autologous stem cell transplantation (ASCT) Sponsors: Nanjing University School of Medicine Recruiting

https://clinicaltrials.gov/study/NCT06376214

Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials

More News: Amyloidosis | Research | Stem Cell Therapy | Stem Cells | Transplants